L-Dopa: Uses, Efficacy, and Genetic Considerations

1) Conditions Studied for L-Dopa Treatment

• Parkinson's Disease
• Dopamine-responsive dystonia
• Restless Legs Syndrome (RLS)

2) Efficacy in Treating Those Conditions

L-Dopa is considered effective in managing symptoms of Parkinson's Disease and improving motor function. It is also used to treat dopamine-responsive dystonia with notable success. For Restless Legs Syndrome, L-Dopa can alleviate symptoms, though it may not be the first line of treatment.

3) Health Benefits of L-Dopa

• Improvement in motor control for patients with Parkinson's Disease and dopamine-responsive dystonia.
• Reduction in the severity of Restless Legs Syndrome.
• Potential improvement in mood and reduction of depression symptoms, as dopamine is a key neurotransmitter in mood regulation.

4) Downsides of L-Dopa

• Long-term use can lead to a phenomenon known as "L-Dopa induced dyskinesia," particularly in Parkinson's patients.
• May cause side effects such as nausea, dizziness, and orthostatic hypotension.
• Effectiveness may diminish over time as the disease progresses.

5) Genetic Variations and L-Dopa

The efficacy and side effects of L-Dopa may vary based on genetic factors. Certain genetic variations in the dopamine receptors or enzymes involved in dopamine metabolism can influence how an individual responds to L-Dopa treatment. For example, variations in the COMT gene that affect the metabolism of dopamine might necessitate dosage adjustments. However, more research is needed to fully understand these interactions and to personalize treatment for optimal outcomes.

Research Summary on L-DOPA

Antioxidant Properties and Diabetes Management

Studies on wild legume seeds in India revealed notable levels of L-DOPA, which have antioxidant properties and show potential in managing type II diabetes through enzyme inhibition activities. Sesbania bispinosa was highlighted for its high L-DOPA content.

Poultry Feed and Growth Performance

Treatment of velvet bean seeds with sodium bicarbonate and autoclaving reduced antinutritional compounds like L-DOPA. Substituting soybean meal protein with treated velvet bean meal in broiler diets improved growth performance in broiler chickens without adverse effects.

Reducing L-DOPA in Mucuna Beans

Various cooking methods were explored to lower L-DOPA in Mucuna beans. The most effective method was treating beans with Ca(OH)2 at pH 9 and washing with hot water, which reduced L-DOPA by 80.4%.

Gravity's Effect on L-DOPA Distribution

3D-clinorotation, simulating microgravity, affected the distribution of L-DOPA in Mucuna pruriens roots and influenced the growth of lettuce roots. Visualization of L-DOPA production was possible due to its conversion to melanin.

Natural Sources of L-DOPA in Parkinson's Treatment

Mucuna pruriens and Vicia faba pods, being natural L-DOPA sources, have shown anti-parkinsonism activity, which might be more effective than synthetic alternatives.

Dietary Effects of L-DOPA on Guinea Fowls

Cracked and cooked Mucuna pruriens beans, high in L-DOPA, can be safely added to guinea fowl diets up to 120 g/kg. Cooking significantly reduced L-DOPA content and improved digestibility.

Levodopa Bioavailability in Parkinson's Disease

Long-term levodopa use in Parkinson's disease (PD) patients leads to increased plasma bioavailability of the drug, potentially affecting treatment efficacy.

L-DOPA's Impact on Hormone Levels

Chronic high-dose L-DOPA administration in male rats influenced hormone levels, particularly luteinizing hormone (LH), and had implications for sexual and reproductive functions.

L-DOPA and Reproductive Health in Japanese Quail

Dietary inclusion of Mucuna pruriens, rich in L-DOPA, enhanced reproductive organ development and function in Japanese quail, linking the dopaminergic system to reproductive health.

Sexual Function and Dopamine Agonists

Studies on the effects of dopamine agonists like apomorphine (Apo) indicated a role of dopamine in normal erectile function, with potential therapeutic implications for erectile dysfunction.

Compulsive Behaviors Linked to Dopamine Agonists

Research highlighted the occurrence of compulsive gambling and hypersexuality in PD patients on therapeutic doses of dopamine agonists, emphasizing the importance of physician awareness.

Gender Differences in Levodopa Response

A study on the effects of levodopa on sexual response found gender-specific differences, with men showing increased Achilles tendon reflex in response to sexual stimulation.

Dopamine's Role in Reinforcement and Motivation

Evidence suggests that dopamine is involved in the motivation to work for rewards rather than directly influencing the desire to consume food, thus affecting demand elasticity for food.

Role of Caffeine in Parkinson's Disease

Caffeine may offer neuroprotective effects and improve both motor and non-motor symptoms in PD, potentially delaying disease onset and progression.

References:

1. Bioactive compounds extracted from Indian wild legume seeds: antioxidant and type II diabetes-related enzyme inhibition properties
2. Studies on the incorporation of velvet bean (Mucuna pruriens var. utilis) as an alternative protein source in poultry feed and its effect on growth performance of broiler chickens
3. [Effect of different cooking treatments of Mucuna beans on its L-Dopa content]
4. Distribution of L-DOPA in the root of velvet bean plant (Mucuna pruriens L.) and gravity
5. Herbs containing L- Dopa: An update
6. Nutrient digestibility of Mucuna (Mucuna pruriens var. utilis) bean in guinea fowl (Numida meleagris, L): Effects of heat treatment and levels of incorporation in diets
7. Chronic levodopa intake increases levodopa plasma bioavailability in patients with Parkinson's disease
8. Effect of chronic L-dopa administration on serum luteinizing hormone levels in male rats
9. Mucuna pruriens seed powder feeding influences reproductive conditions and development in Japanese quail Coturnix coturnix japonica
10. Effect of L-dihydroxyphenylalanine upon serum growth hormone concentrations in children and adolescents
11. Influence of levodopa on serum levels of anterior pituitary hormones in man
12. Acute levodopa administration reduces cortisol release in patients with Parkinson's disease
13. Effects of levodopa on nocturnal penile tumescence: a preliminary study
14. Effect of apomorphine, a dopamine receptor agonist, on penile tumescence in normal subjects
15. Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease
16. Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy
17. Effect of a single dose of levodopa on sexual response in men and women
18. Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine
19. Dopamine and sexual function
20. Clinical effects of amphetamine and L-DOPA on sexuality and aggression
21. Growth hormone response to L-dopa and pyridostigmine in women with polycystic ovarian syndrome
22. Reduced growth hormone response to L-dopa and pyridostigmine in obesity
23. Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression
24. Acipimox potentiates growth hormone (GH) response to GH-releasing hormone with or without pyridostigmine by lowering serum free fatty acid in normal and obese subjects
25. Strong inhibitory effects of common tea catechins and bioflavonoids on the O-methylation of catechol estrogens catalyzed by human liver cytosolic catechol-O-methyltransferase
26. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors
27. Progress in Parkinson's disease-where do we stand?
28. Beneficial effects of natural phenolics on levodopa methylation and oxidative neurodegeneration
29. L-3,4-dihydroxyphenylalanine (levodopa) lowers central nervous system S-adenosylmethionine concentrations in humans
30. Priming for l-dopa-induced dyskinesia in Parkinson's disease: a feature inherent to the treatment or the disease?
31. L-DOPA-induced dyskinesia is associated with regional increase of striatal dynorphin peptides as elucidated by imaging mass spectrometry
32. Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson's disease
33. Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson's disease
34. Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias
35. L-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated Transmission
36. Effects of caffeine in Parkinson's disease: from neuroprotection to the management of motor and non-motor symptoms
37. Nigrostriatal damage is required for induction of dyskinesias by L-DOPA in squirrel monkeys

Upload Whole Genome Sequencing (WGS) raw DNA data today and take a deep dive into your genome!

Or if you only have standard microarray data currently, upload raw DNA data to get started with your free DNA raw data analysis today!